The novel finding of the study was that LESW therapy improved hepatic fibrosis, hepatic function, and hepatic angiogenesis, accompanied by down-regulation of TGF-β1 and up-regulation of angiogenic factors such as bFGF and VEGF-B. This evidence concerns the gene VEGFB and Hepatic fibrosis.